iShares MSCI Indonesia ETF vs 10X Genomics Inc — how do they compare? iShares MSCI Indonesia ETF trades at $12.47, while 10X Genomics Inc trades at $59.23 (market cap $7.61B). The key difference: 10X Genomics Inc is trading nearer its 52-week high, iShares MSCI Indonesia ETF nearer its low. Which is the better fit depends on your goals.
| EIDO | TXG | |
|---|---|---|
52-Week High | $19.22 | $58.57 |
52-Week Low | $10.80 | $11.34 |
Market Cap | — | $7.61B |
Sector | — | Health |
Enterprise Value | — | $7.14B |
Trailing returns across standard periods
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →